Psychiatry Tomorrow The SPRAVATO® Story with Dr. Hussesini K. Manji,
Oct 24, 2024
Dr. Husseini K. Manji, a visionary scientist behind esketamine, discusses its groundbreaking development as a treatment for depression. He shares insights into targeting NMDA receptors and the rigorous clinical trials leading to FDA approval. The conversation highlights the challenges of introducing novel psychiatric drugs, including regulatory hurdles and insurance issues. Dr. Manji also addresses the broader implications for mental health treatment and the promising future of psychedelic medicine, emphasizing the need for equality in mental health care.
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 4min
Exploring Synaptic Mechanisms and Depression Treatment
04:26 • 3min
Revolutionizing Depression Treatment with Ketamine
07:05 • 9min
Collaborative Development of Esketamine for Depression Treatment
16:19 • 3min
Exploring First-Line Treatment Options in Depression Management
19:40 • 4min